oxprenolol has been researched along with Angioimmunoblastic Lymphadenopathy in 1 studies
Oxprenolol: A beta-adrenergic antagonist used in the treatment of hypertension, angina pectoris, arrhythmias, and anxiety.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The association of AILD and myelofibrosis has been rarely encountered and is hereby discussed." | 1.27 | Severe pancytopenia due to marked marrow fibrosis associated with angioimmunoblastic lymphadenopathy. ( Ben Arieh, Y; Brenner, B; Green, J; Nagler, A; Rosenbaum, H; Tatarsky, I, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brenner, B | 1 |
| Green, J | 1 |
| Rosenbaum, H | 1 |
| Ben Arieh, Y | 1 |
| Nagler, A | 1 |
| Tatarsky, I | 1 |
1 other study available for oxprenolol and Angioimmunoblastic Lymphadenopathy
| Article | Year |
|---|---|
Severe pancytopenia due to marked marrow fibrosis associated with angioimmunoblastic lymphadenopathy.
Topics: Angina Pectoris; Humans; Immunoblastic Lymphadenopathy; Oxprenolol; Pancytopenia; Prednisone; Primar | 1985 |